论文部分内容阅读
目的研究经尿道前列腺电切术与经尿道前列腺等离子电切术治疗前列腺增生的临床效果。方法将濮阳市油田总医院128例前列腺增生症患者以随机数表法分为电切组和等离子组,每组64例,电切组采取经尿道前列腺电切术治疗,等离子组采取经尿道前列腺等离子电切术治疗,比较两组手术出血量、手术时间、住院时间、血糖、血钠、前列腺症状评分(IPSS)、生活质量指数(QOL)、最大尿流率(Qmax)、残余尿量(RUV)及不良反应发生率。结果电切组手术出血量、术后血糖值分别为(241.36±51.52)ml、(9.87±2.64)mmol/L,显著高于等离子组的(134.64±46.07)ml、(5.12±2.96)mmol/L,差异有统计学意义(P<0.05);电切组术后血钠值为(130.58±8.31)mmol/L,显著低于等离子组的(136.34±6.28)mmol/L,差异有统计学意义(P<0.05);两组手术时间及住院时间比较差异未见统计学意义(P>0.05);两组术后IPSS、QOL、RUV显著低于术前(P<0.05),Qmax均高于术前(P<0.05),但组间各指标比较差异未见统计学意义(P>0.05);电切组总发生率为20.31%,与等离子组的7.81%比较差异有统计学意义(P<0.05)。结论经尿道前列腺电切术与经尿道前列腺等离子电切术均为治疗前列腺增生的有效方式,而经尿道前列腺等离子电切术手术出血量较低,对血糖及血钠无明显影响,不良反应较低,应作为优选方案进行治疗。
Objective To study the clinical effect of transurethral resection of the prostate and transurethral resection of the prostate on the treatment of benign prostatic hyperplasia. Methods 128 patients with benign prostatic hyperplasia in Puyang Oilfield General Hospital were divided into two groups according to the random number table: electrosurgical group and plasma group, 64 cases in each group. Transurethral resection of the prostate was performed in the resection group. The transurethral prostate The patients were divided into two groups: operation, plasma flow, hospitalization, blood glucose, serum sodium, IPSS, QOL, Qmax, residual urine volume RUV) and the incidence of adverse reactions. Results The blood loss and postoperative blood glucose were (241.36 ± 51.52) ml and (9.87 ± 2.64) mmol / L, respectively, which were significantly higher than those in the plasma group (134.64 ± 46.07 and. L, the difference was statistically significant (P <0.05). The serum sodium level after the resection was (130.58 ± 8.31) mmol / L, which was significantly lower than that of the plasma (136.34 ± 6.28) mmol / L, (P <0.05). There was no significant difference in the operation time and hospital stay between the two groups (P> 0.05). The IPSS, QOL and RUV of the two groups were significantly lower than those before operation (P <0.05) (P <0.05), but there was no significant difference between the groups (P> 0.05). The total incidence of resection was 20.31%, which was significantly different from 7.81% of plasma (P <0.05) P <0.05). Conclusions Transurethral resection of the prostate and transurethral resection of the prostate plasma are effective methods for the treatment of benign prostatic hyperplasia. However, the transurethral resection of prostatectomy has a lower amount of bleeding and no significant effect on blood glucose and serum sodium. The adverse reactions Low, should be treated as a preferred option.